Hannah F. Wingate

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers”.

Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

Cancer Research(2023)10.1158/0008-5472.can-23-0705

N/A

0DataRank · unranked

53 citations

Nicole M. Kettner, Xiayu Rao, Cassandra Santaella Bishop, Tuyen Bui, Hannah F. Wingate +10 more

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer

Annals of Surgical Oncology(2023)10.1245/s10434-022-12972-5

N/A

0DataRank · unranked

21 citations

Vera J. Suman, Hannah F. Wingate, A. Marilyn Leitch, Gary Unzeitig, Judy C. Boughey +4 more

Data from Low-Molecular-Weight Cyclin E Can Bypass Letrozole-Induced G1 Arrest in Human Breast Cancer Cells and Tumors

(2023)10.1158/1078-0432.c.6517767

N/A

0DataRank · unranked

0 citations

Tuyen Bui, Hannah F. Wingate, Anna Biernacka, Stacy Moulder, Susan L. Tucker +3 more

Data from Low-Molecular-Weight Cyclin E Can Bypass Letrozole-Induced G1 Arrest in Human Breast Cancer Cells and Tumors

(2023)10.1158/1078-0432.c.6517767.v1

N/A

0DataRank · unranked

0 citations

Tuyen Bui, Hannah F. Wingate, Anna Biernacka, Stacy L. Moulder, Susan L. Tucker +3 more

IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-01041-1

N/A

0DataRank · unranked

14 citations

Tuyen Bui, Juliana Navarro-Yepes, Sanaz Ghotbaldini, Bethanie Quintela, Catherine K. Luo +19 more

Correction: Impact of Pathologic Complete Response on Local-Regional Recurrence and Survival in Patients Undergoing Neoadjuvant Systemic Therapy and Breast-Conserving Surgery

Annals of Surgical Oncology(2025)10.1245/s10434-025-18401-7

N/A

0DataRank · unranked

0 citations

Alexa Glencer, Min Yi, Emma Wingate, Hannah F. Wingate, Naid Allassan +6 more